bf/NASDAQ:DAWN_icon.jpeg

COM:DAYONEBIO

Day One Bio

  • Stock

Last Close

13.62

21/11 16:09

Market Cap

1.29B

Beta: -

Volume Today

314.37K

Avg: -

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive ...Show More

invested in